UW Medicine

Dog Aging Project Featured in Nature

Dog Aging Project Featured in Nature
The Nature article describes the second part of the project which would test an FDA-approved Healthspan-lengthening drug, called rapamycin, in the hopes of improving the health of aging dogs.

HALo’s Dog Aging Project—which hopes to develop treatments to slow aging and provide dogs and cats with three to five or more years of additional healthy, youthful life—was featured in an October 29th Nature article “Pet dogs set to test anti-ageing drug”. 

Low doses of rapamycin have been shown to safely slow aging and extend the period of healthy life in mice and several other organisms. Based on our scientific studies, we anticipate that the drug will improve cardiac function, boost immune function, reduce or delay the risk of cancer, and increase healthy lifespan of middle-aged dogs by two to five years.

Read more about The Dog Aging Project

Apply to enroll your dog in the study

Read the full Nature article here